Business
Organigram Update on Proposed Investment in European CBD Hemp Producer Eviana
Organigram Update on Proposed Investment in European CBD Hemp Producer Eviana Cana...
About this update from Organigram Global Inc.
[{"type":"text","content":"\n\n\n\nOrganigram Update on Proposed Investment in European CBD Hemp Producer Eviana\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\n\n\nCanada NewsWire\nMONCTON, NB, Sept. 14, 2018\n\n\n\nOrganigram and Strategic Investor to Collectively Participate in $10 Million Private Placement Debenture into Eviana Health Corporation\n MONCTON, NB, Sept. 14, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (the \"Company\" or \"Organigram\"), a leading licensed producer of medical marijuana, is pleased to update the market on its proposed investment in Eviana Health Corporation (\"Eviana\"). The information provided in this news release is meant to update and replace the information previously disseminated by Organigram on June 4, 2018 regarding a proposed investment in Eviana.\n\n \n \n\n \nPrivate Placement Investment in Eviana Debentures\nOrganigram has signed a term sheet to participate as to 50% in a private placement debenture offering (the \"Debenture Offering\") by Eviana comprised of 10,000 debenture units (the \"Debenture Units\") of Eviana, each consisting of: (i) $1,000 principal amount of senior unsecured convertible debentures of Eviana (the \"Debenture\") and (ii) one half of one common share (the \"Common Shares\") purchase warrant of the Company (each whole purchase warrant, a \"Warrant\"). The balance of the Debenture Offering is proposed to be acquired by an institutional strategic investor (the \"Strategic Investor\"). \nEach full Warrant shall be exercisable by the holder thereof for 870 Common Shares in the capital of Eviana at an exercise price per Warrant Share of $1.30 for a period of 24 months from the closing date of the Debenture Offering. The Debentures will be convertible at a conversion price of $1.15 per Common Share at the holder's option, or upon mandatory conversion at the request of Eviana in the event that at any time following four months plus one day following the Closing, for any ten consecutive trading days, the daily volume weighted ...